Dr. Reddy's Laboratories Cash Flow Statement
NYSE: RDYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Dr. Reddy's Laboratories free cash flow
In fiscal 2025, Dr. Reddy's Laboratories generated $545.0 million of operating cash flow and spent $322.0 million on capital expenditures. That left free cash flow of $223.0 million, a free-cash-flow margin of 5.9% of revenue. Free cash flow was down 35.9% from the prior year's $348.0 million.
Dr. Reddy's Laboratories returned $78.0 million to shareholders through dividends, equal to 35% of free cash flow. Free cash flow covered dividend payments 2.9 times.
Summary generated from market data by MetaCap's automated system. Methodology
Dr. Reddy's Laboratories cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-03-31 | FY 20242024-03-31 | FY 20232023-03-31 | FY 20222022-03-31 | FY 20212021-03-31 | FY 20202020-03-31 | FY 20192019-03-31 | FY 20182018-03-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | 671.00M | 668.00M | 548.00M | 311.00M | 236.00M | 259.00M | 272.00M | 151.00M |
| Net Income growth (YoY) | +0.45% | +21.90% | +76.21% | +31.78% | -8.88% | -4.78% | +80.13% | — |
| Depreciation & Amortization | 200.00M | 178.00M | 154.00M | 156.00M | 175.00M | 165.00M | 176.00M | 180.00M |
| Stock-Based Compensation | 5.00M | 5.00M | 5.00M | 8.00M | 8.00M | 7.00M | 6.00M | 7.00M |
| Operating Cash Flow | 545.00M | 545.00M | 716.00M | 370.00M | 488.00M | 396.00M | 415.00M | 277.00M |
| Capital Expenditures | -322.00M | -197.00M | -138.00M | -193.00M | -133.00M | -64.00M | -101.00M | -143.00M |
| Investing Cash Flow | -682.00M | -483.00M | -503.00M | -348.00M | -310.00M | -65.00M | -112.00M | -229.00M |
| Dividends Paid | -78.00M | -80.00M | -61.00M | -55.00M | -57.00M | -52.00M | -58.00M | -61.00M |
| Share Repurchases | — | — | — | 0 | — | — | 0 | 0 |
| Debt Issued | 0 | 46.00M | — | — | 52.00M | — | — | — |
| Debt Repaid | 0 | -46.00M | — | — | — | — | — | — |
| Financing Cash Flow | 222.00M | -45.00M | -327.00M | -32.00M | -4.00M | -334.00M | -308.00M | -68.00M |
| Free Cash Flow | 223.00M | 348.00M | 578.00M | 177.00M | 355.00M | 332.00M | 314.00M | 134.00M |
This table shows 8 annual periods of Dr. Reddy's Laboratories's cash flow statement, from FY 2025 back to FY 2018, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow RDY's reporting calendar. What is a cash flow statement?